Device type · JXG
Shunt, Central Nervous System And Components
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JXG
Neurology
Device class
Class II
FDA decisions since 2015
54
510(k), De Novo and PMA
Adverse event reports
1,152
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Shunt, Central Nervous System And Components
- Product code
- JXG
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5550
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for JXG
Latest FDA decisions
The 8 newest of 54 since 2015.
K260044 · Decided Oct 2, 2026 · 268 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
Integra Lifesciences Production Corporation
K261004 · Decided Jun 23, 2026 · 89 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
- Intellidrop510(k)
K251598 · Decided Dec 10, 2025 · 197 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
K250636 · Decided Nov 28, 2025 · 270 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
- EVAC-MRI510(k)
K252514 · Decided Nov 5, 2025 · 86 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
Integra Lifesciences Production Corporation
K243531 · Decided Aug 8, 2025 · 267 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
Integra Lifesciences Production Corporation
K243552 · Decided Aug 6, 2025 · 264 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
K242974 · Decided Jun 20, 2025 · 267 days after receipt
Device type: Shunt, Central Nervous System And Components (JXG) · Neurology & Neurosurgery
Reports received
1,152
Received Nov 1, 2025 to Nov 19, 2026. Includes 8 of another or unstated type.
Malfunction reports
432
38% of reports
Injury reports
694
60% of reports
Death reports
18
1.6% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 16 | 73 | 1 | 0 |
| Jan 24 | 36 | 43 | 0 | 1 |
| Feb 24 | 30 | 72 | 0 | 1 |
| Mar 24 | 18 | 63 | 0 | 0 |
| Apr 24 | 31 | 61 | 0 | 0 |
| May 24 | 40 | 68 | 0 | 0 |
| Jun 24 | 30 | 50 | 1 | 1 |
| Jul 24 | 24 | 73 | 2 | 0 |
| Aug 24 | 39 | 68 | 0 | 0 |
| Sep 24 | 55 | 65 | 0 | 0 |
| Oct 24 | 38 | 73 | 0 | 1 |
| Nov 24 | 56 | 64 | 0 | 0 |
| Dec 24 | 44 | 66 | 0 | 0 |
| Jan 25 | 34 | 51 | 0 | 0 |
| Feb 25 | 20 | 63 | 0 | 0 |
| Mar 25 | 26 | 69 | 0 | 0 |
| Apr 25 | 39 | 56 | 3 | 0 |
| May 25 | 45 | 59 | 1 | 0 |
| Jun 25 | 59 | 65 | 0 | 0 |
| Jul 25 | 39 | 69 | 1 | 0 |
| Aug 25 | 38 | 73 | 0 | 0 |
| Sep 25 | 27 | 51 | 1 | 0 |
| Oct 25 | 48 | 66 | 2 | 0 |
| Nov 25 | 44 | 62 | 1 | 0 |
| Dec 25 | 38 | 69 | 0 | 0 |
| Jan 26 | 37 | 55 | 0 | 0 |
| Feb 26 | 39 | 48 | 0 | 0 |
| Mar 26 | 53 | 51 | 4 | 0 |
| Apr 26 | 45 | 67 | 1 | 0 |
| May 26 | 43 | 58 | 0 | 0 |
| Jun 26 | 34 | 59 | 5 | 0 |
| Jul 26 | 29 | 61 | 0 | 3 |
| Aug 26 | 27 | 70 | 0 | 4 |
| Sep 26 | 17 | 50 | 4 | 1 |
| Oct 26 | 26 | 44 | 3 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Obstruction of Flow269
- Break176
- Infusion or Flow Problem172
- Physical Resistance/Sticking166
- Insufficient Device Problem Information103
- Fracture70
- Fluid/Blood Leak68
- Complete Blockage49
- Failure to Align41
- Adverse Event Without Identified Device or Use Problem40
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Hydrocephalus405
- No Clinical Signs, Symptoms or Conditions397
- Insufficient Information162
- Headache40
- Unspecified Infection36
- Bacterial Infection16
- Cerebrospinal Fluid Leakage15
- Intracranial Hemorrhage15
- Vomiting12
- Cerebral Ventriculomegaly11
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Integra LifeSciences Corp. (NeuroSciences)
Z-2173-2026 · Started Apr 10, 2026 · Posted by FDA May 13, 2026
Reason given: Out-of-specification endotoxin result that did not meet the acceptance criteria.
Cause as FDA categorized it: Process control
Z-0977-2025 · Started Dec 16, 2024 · Posted by FDA Jan 17, 2025
Reason given: Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.
Cause as FDA categorized it: Labeling Change Control
Z-0978-2025 · Started Dec 16, 2024 · Posted by FDA Jan 17, 2025
Reason given: Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.
Cause as FDA categorized it: Labeling Change Control
Z-0979-2025 · Started Dec 16, 2024 · Posted by FDA Jan 17, 2025
Reason given: Potential for certain SKUs and lot numbers were distributed with the incorrect product description on the internal and external labels.
Cause as FDA categorized it: Labeling Change Control
Z-2136-2024 · Started May 7, 2024 · Posted by FDA Jun 12, 2024
Reason given: Defect in the external sterile packaging (pouch) leading to a gap or/and weakness of the seal that may compromise the product sterility.
Cause as FDA categorized it: Process control
Z-2137-2024 · Started May 7, 2024 · Posted by FDA Jun 12, 2024
Reason given: Defect in the external sterile packaging (pouch) leading to a gap or/and weakness of the seal may compromise the product sterility.
Cause as FDA categorized it: Process control
Z-2138-2024 · Started May 7, 2024 · Posted by FDA Jun 12, 2024
Reason given: Defect in the external sterile packaging (pouch) leading to a gap or/and weakness of the seal may compromise the product sterility.
Cause as FDA categorized it: Process control
Z-0634-2024 · Started Nov 28, 2023 · Posted by FDA Jan 4, 2024
Reason given: Sterility assurance cannot be guaranteed for external drainage systems due to incomplete bioburden testing.
Cause as FDA categorized it: Process change control
Showing the 8 newest of 108 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.